Skip to content

Evaluation of the Effect of Food, Itraconazole, and Rifampicin on the Single-Dose Pharmacokinetics of Naronapride.

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-520215-40-00
Acronym
NAT-024/BIO
Enrollment
48
Registered
2025-08-21
Start date
2025-09-09
Completion date
2026-01-02
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No medical condition.

Interventions

None listed

Sponsors

Dr. Falk Pharma GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Portugal

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026